Use of an agonistic analog of gonadotropin-releasing hormone (nafarelin) to treat leiomyomas: Assessment by magnetic resonance imaging
- 1 April 1988
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 158 (4), 903-910
- https://doi.org/10.1016/0002-9378(88)90092-0
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Dose-Dependent Inhibition of Pituitary-Ovarian Function during Administration of a Gonadotropin-Releasing Hormone Agonistic Analog (Nafarelin)*Journal of Clinical Endocrinology & Metabolism, 1986
- RAPID REDUCTION OF UTERINE MYOMAS AFTER SHORT-TERM TREATMENT WITH MICROENCAPSULATED D-Trp6-LHRHThe Lancet, 1986
- Treatment of Hirsutism with a Gonadotropin-Releasing Hormone Agonist (Nafarelin)∗Journal of Clinical Endocrinology & Metabolism, 1986
- Toward Removing Uterine Fibroids without Surgery: Subcutaneous Infusion of a Luteinizing Hormone-Releasing Hormone Agonist Commencing in the Luteal PhaseJournal of Clinical Endocrinology & Metabolism, 1986
- Long-acting gonadotropin hormone-releasing hormone analogused to treat uteriFertility and Sterility, 1986
- Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms.Radiology, 1986
- Luteinizing hormone-releasing hormone agonist and uterine leiomyoma: A pilot studyAmerican Journal of Obstetrics and Gynecology, 1985
- COMPARISON OF CELLULAR LEVELS OF STEROID RECEPTORS IN UTERINE LEIOMYOMA AND MYOMETRIUMActa Obstetricia et Gynecologica Scandinavica, 1985
- Synthesis and biological activity of some very hydrophobic superagonist analogs of luteinizing hormone-releasing hormoneJournal of Medicinal Chemistry, 1982
- Regulation of Human Gonadotropins: X. Episodic Fluctuation of LH During the Menstrual Cycle1Journal of Clinical Endocrinology & Metabolism, 1971